CENTRAL TRUST Co reduced its position in shares of Cerner Co. (NASDAQ:CERN) by 13.5% in the first quarter, according to its most recent filing with the SEC. The fund owned 8,948 shares of the company’s stock after selling 1,400 shares during the quarter. CENTRAL TRUST Co’s holdings in Cerner were worth $512,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Essex Savings Bank bought a new stake in Cerner in the fourth quarter worth $27,000. Moody National Bank Trust Division lifted its position in shares of Cerner by 72.5% during the first quarter. Moody National Bank Trust Division now owns 483 shares of the company’s stock worth $28,000 after purchasing an additional 203 shares during the last quarter. JNBA Financial Advisors bought a new stake in shares of Cerner during the fourth quarter worth $34,000. Creative Financial Designs Inc. ADV lifted its position in shares of Cerner by 303.4% during the first quarter. Creative Financial Designs Inc. ADV now owns 710 shares of the company’s stock worth $41,000 after purchasing an additional 534 shares during the last quarter. Finally, Financial Gravity Companies Inc. bought a new stake in shares of Cerner during the fourth quarter worth $44,000. Hedge funds and other institutional investors own 80.16% of the company’s stock.
In related news, Director R Halsey Wise bought 7,600 shares of the business’s stock in a transaction on Tuesday, April 30th. The shares were bought at an average price of $65.76 per share, for a total transaction of $499,776.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Julie M. Wilson sold 93,500 shares of the business’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $69.57, for a total value of $6,504,795.00. Following the sale, the executive vice president now owns 45,510 shares in the company, valued at approximately $3,166,130.70. The disclosure for this sale can be found here. Insiders sold 151,968 shares of company stock worth $10,552,989 in the last quarter. 4.71% of the stock is owned by insiders.
Several analysts have recently weighed in on CERN shares. Zacks Investment Research downgraded Cerner from a “hold” rating to a “sell” rating in a research report on Monday, March 11th. ValuEngine upgraded Cerner from a “hold” rating to a “buy” rating in a research report on Wednesday, May 1st. BidaskClub upgraded Cerner from a “sell” rating to a “hold” rating in a research report on Wednesday, February 13th. Robert W. Baird raised their price target on Cerner from $67.00 to $71.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of Cerner in a research note on Monday, April 29th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $69.19.
CERN traded down $0.02 on Wednesday, hitting $70.13. The company had a trading volume of 2,137,998 shares, compared to its average volume of 2,518,192. Cerner Co. has a 12-month low of $48.78 and a 12-month high of $70.76. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.58 and a quick ratio of 2.55. The firm has a market capitalization of $22.27 billion, a PE ratio of 31.73, a price-to-earnings-growth ratio of 2.10 and a beta of 1.03.
Cerner (NASDAQ:CERN) last posted its earnings results on Thursday, April 25th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.55 by $0.06. Cerner had a return on equity of 14.86% and a net margin of 11.65%. The company had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same quarter in the previous year, the firm earned $0.58 earnings per share. The firm’s quarterly revenue was up 7.5% compared to the same quarter last year. As a group, sell-side analysts expect that Cerner Co. will post 2.44 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Sundance Herald and is owned by of Sundance Herald. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://sundanceherald.com/2019/05/22/central-trust-co-trims-stake-in-cerner-co-cern.html.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Featured Story: What defines an oversold asset?
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.